Showing results (11-20 of 33) with videos related to
Sort By:
Pageof 4
Cancer Biomarkers : Section a of Disease Markers|December 20, 2014
The identification and characterization of a STAT5 gene signature in hematologic malignanciesDmitriy Sonkin, Michael Palmer, Xianhui Rong, et al.Plos One|November 17, 2012
RAD001 enhances the potency of BEZ235 to inhibit mTOR signaling and tumor growthBeat Nyfeler, Yan Chen, Xiaoyan Li, et al.Nature Medicine|August 9, 2011
Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway-dependent and PI3K pathway-independent mechanismsPixu Liu, Hailing Cheng, Stephanie Santiago, et al.Cancer Research|December 20, 2007
A Smac mimetic rescue screen reveals roles for inhibitor of apoptosis proteins in tumor necrosis factor-alpha signalingAlex Gaither, Dale Porter, Yao Yao, et al.Elife|May 22, 2014
MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cellsYubao Wang, Young-Mi Lee, Lukas Baitsch, et al.Cancer Research|September 24, 2016
High-Order Drug Combinations Are Required to Effectively Kill Colorectal Cancer CellsThomas Horn, Stéphane Ferretti, Nicolas Ebel, et al.Proceedings of the National Academy of Sciences of the United States of America|September 28, 2011
Maintenance of adenomatous polyposis coli (APC)-mutant colorectal cancer is dependent on Wnt/beta-catenin signalingAlix Scholer-Dahirel, Michael R Schlabach, Alice Loo, et al.Genes & Cancer|October 30, 2013
Overexpression of HGF Promotes HBV-Induced Hepatocellular Carcinoma Progression and Is an Effective Indicator for Met-Targeting TherapyQian Xie, Yanli Su, Karl Dykema, et al.Molecular Cancer Therapeutics|March 1, 2015
Loss of Tuberous Sclerosis Complex 2 (TSC2) Is Frequent in Hepatocellular Carcinoma and Predicts Response to mTORC1 Inhibitor EverolimusHung Huynh, Huai-Xiang Hao, Stephen L Chan, et al.Plos One|June 16, 2015
Patterns of HER2 Gene Amplification and Response to Anti-HER2 TherapiesRocio Vicario, Vicente Peg, Beatriz Morancho, et al.Pageof 4